Osaic Holdings
CRDL

Osaic Holdings’s Cardiol Therapeutics CRDL Stock Holding History

Osaic Holdings’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$675 Sell
500
-187
-27% -$192 ﹤0.01% 7370
2025
Q4 		$659 Sell
687
-1,032
-60% -$1.08K ﹤0.01% 7389
2025
Q3 		$1.88K Sell
1,719
-2,295
-57% -$2.79K ﹤0.01% 7157
2025
Q2 		$5.45K Sell
4,014
-275
-6% -$320 ﹤0.01% 6494
2025
Q1 		$4.1K Buy
4,289
+545
+15% +$669 ﹤0.01% 6276
2024
Q4 		$4.81K Buy
3,744
+2,544
+212% +$4.29K ﹤0.01% 6220
2024
Q3 		$2.38K Hold
1,200
– – ﹤0.01% 6546
2024
Q2 		$2.42K Sell
1,200
-24,400
-95% -$51.8K ﹤0.01% 6521
2024
Q1 		$46.3K Sell
25,600
-41,200
-62% -$55.5K ﹤0.01% 4807
2023
Q4 		$56.3K Sell
66,800
-2,000
-3% -$1.7K ﹤0.01% 4833
2023
Q3 		$61.6K Buy
68,800
+2,000
+3% +$1.91K ﹤0.01% 4840
2023
Q2 		$59.5K Buy
66,800
+30,000
+82% +$19.8K ﹤0.01% 4819
2023
Q1 		$17.9K Sell
36,800
-37,910
-51% -$22.4K ﹤0.01% 5630
2022
Q4 		$38K Buy
74,710
+51,870
+227% +$31.6K ﹤0.01% 5129
2022
Q3 		$24K Sell
22,840
-67,464
-75% -$82.2K ﹤0.01% 5433
2022
Q2 		$120K Sell
90,304
-22,754
-20% -$32.4K ﹤0.01% 4263
2022
Q1 		$173K Buy
113,058
+108,228
+2,241% +$179K ﹤0.01% 4155
2021
Q4 		$9K Sell
4,830
-10,970
-69% -$30.3K ﹤0.01% 6321
2021
Q3 		$65K Buy
+15,800
New +$57.3K ﹤0.01% 4907

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings's CRDL Position: Q1 2026 in Review

Osaic Holdings reduced its Cardiol Therapeutics (CRDL) stake by 27% in Q1 2026, selling an estimated $192 and leaving 500 shares worth $675. The position accounts for ﹤0.01% of the portfolio, ranked #7370.

Osaic Holdings first reported a position in CRDL in Q3 2021 and has held it in 19 quarters since. The position peaked at $173K in Q1 2022. 47 funds tracked by Wall St. Rank hold CRDL as of Q1 2026.

  • Osaic Holdings held 500 shares of Cardiol Therapeutics worth $675 as of Q1 2026.
  • Osaic Holdings sold 187 Cardiol Therapeutics shares in Q1 2026, an estimated $192.
  • Cardiol Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7370 holding.
  • Osaic Holdings first reported a position in Cardiol Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Osaic Holdings's Cardiol Therapeutics position peaked at $173K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.